sign in sign up
<<
Home , Alphacetylmethadol

30318 Federal Register / Vol. 60, No. 110 / Thursday, June 8, 1995 / Notices

FOR FURTHER INFORMATION CONTACT: Manufacturer of Controlled Any other such applicant and any Long Range Planning Office, Substances; Notice of Application person who is presently registered with Administrative Office of the United DEA to manufacture such substances States Courts, Suite 4–170, One Pursuant to § 1301.43(a) of Title 21 of may file comments or objections to the Columbus Circle, N.E., Washington, the Code of Federal Regulations (CFR), issuance of the above application and D.C. 20544, 202–273–1810. this is notice that on April 5, 1995, may also file a written request for a Radian Corporation, P.O. Box 201088, Dated: June 1, 1995. hearing thereon in accordance with 21 Mopac Blvd., Austin, Texas 78720, L. Ralph Mecham, CFR 1301.54 and in the form prescribed made application to the Drug by 21 CFR 1316.47. Secretary to the Judicial Conference of the Enforcement Administration (DEA) for Any such comments, objections, or United States. registration as a bulk manufacturer of requests for a hearing may be addressed [FR Doc. 95–14056 Filed 6–7–95; 8:45 am] the basic classes of controlled to the Deputy Assistant Administrator, BILLING CODE 2210±01±M substances listed below: Office of Diversion Control, Drug Enforcement Administration, United Drug Schedule States Department of Justice, DEPARTMENT OF JUSTICE Cathinone (1235) ...... I Washington, D.C. Federal Register Representative (CCR), and must be filed Drug Enforcement Administration Methcathinone (1237) ...... I N-Ethylamphetamine (1475) ...... I no later than July 10, 1995. Manufacturer of Controlled N,N-Dimethylamphetamine (1480) I Dated: May 31, 1995. Substances; Notice of Registration Aminorex (1585) ...... I Gene R. Haislip, 4-Methylaminorex (cis isomer) I By Notice dated April 4, 1995, and (1590). Deputy Assistant Administrator, Office of Methaqualone (2565) ...... I Diversion Control, Drug Enforcement published in the Federal Register on Administration. April 12, 1995, (60 FR 18617), Games Lysergic acid diethylamide (7315) I [FR Doc. 95–13995 Filed 6–7–95; 8:45 am] Chemicals, Inc., Industrial Park Road, (7370) ..... I Mescaline (7381) ...... I BILLING CODE 4410±09±M Pennsville, New Jersey 08070, made 3,4-Methylenedioxyamphetamine I application to the Drug Enforcement (7400). Administration (DEA) to be registered as 3,4-Methylenedioxy-N-ethyl- I Manufacturer of Controlled a bulk manufacturer of the basic classes amphetamine (7404). Substances; Notice of Application of controlled substances listed below: 3,4-Methylenedioxymeth- I amphetamine (7405). Pursuant to § 1301.43(a) of Title 21 of Drug Schedule 4-Methoxyamphetamine (7411) ... I the Code of Federal Regulations (CFR), Psilocybin (7437) ...... I this is notice that on April 24, 1995, Methylphenidate (1724) ...... II Psilocyn (7438) ...... I Research Triangle Institute, Kenneth H. Amobarbital (2125) ...... II (9145) ...... I Davis, Jr., Hermann Building, East (2270) ...... II Normorphine (9313) ...... I Secobarbital (2315) ...... II Acetylemthadol (9601) ...... I Institute Drive, P.O. Box 12194, Glutethimide (2550) ...... II Alphacetylmethadol except Levo- I Research Triangle Park, North Carolina (9250) ...... II Alphacetylmethadol (9603). 27709, made application to the Drug Methadone-intermediate (9254) ... II Normethadone (9635) ...... I Enforcement Administration (DEA) for , bulk (non- II 3-Methylfentanyl (9813) ...... I registration as a bulk manufacturer of dosage forms) (9273). Amphetamine (1100) ...... II the basic classes of controlled Methamphetamine (1105) ...... II substances listed below: Two registered manufacturers filed a Methylphenidate (1724) ...... II written request for a hearing with Amobarbital (2125) ...... II Drug Schedule respect to Methylphenidate (1724). A Pentobarbital (2270) ...... II Secobarbital (2315) ...... II third registered manufacturer filed a Marihuana (7360) ...... I (7471) ...... II (9041) ...... II comment that the firm wishes to 1- II participate if a hearing is requested for Piperidinocyclohexanecarbonitr- The Institute will manufacture Methylphenidate. Therefore, pursuant ile (8603). to Section 303 of the Comprehensive (9120) ...... II Marihuana cigarettes for the National Drug Abuse Prevention and Control Act (9143) ...... II Institute on Drug Abuse (NIDA) and the of 1970 and Title 21, Code of Federal (9150) ...... II Cocaine will be used for reference Regulations, Section 1301.54(e), the (9170) ...... II standards, human and animal research, Deputy Assistant Administrator, Office Benzoylecgonine (9180) ...... II as dictated by NIDA. (9190) ...... II Any other such applicant and any of Diversion Control, hereby orders that (9193) ...... II the application submitted by the above person who is presently registered with (9226) ...... II DEA to manufacture such substances firm for registration as a bulk Meperidine (9230) ...... II manufacturer of the basic classes of may file comments or objections to the Methadone (9250) ...... II issuance of the above application and controlled substances listed above is Methadone-intermediate (9254) ... II granted with the exception of (9300) ...... II may also file a written request for a Methylphenidate (1724). Levo-alphacetylmethadol (9648) .. II hearing thereon in accordance with 21 (9652) ...... II CFR 1301.54 and in the form prescribed Dated: May 31, 1995. (9737) ...... II by 21 CFR 1316.47. Gene R. Haislip, (9740) ...... II Any such comments, objections, or Deputy Assistant Administrator, Office of (9801) ...... II requests for a hearing may be addressed Diversion Control, Drug Enforcement to the Deputy Assistant Administrator, Administration. The firm plans to manufacture Office of Diversion Control, Drug [FR Doc. 95–13996 Filed 6–7–95; 8:45 am] deuterated and non-deuterated Enforcement Administration, United BILLING CODE 4410±09±M analytical reference standards. States Department of Justice,